Self-Stigma in Patients with Endogenous Mental Disorders: A Cross-Sectional Comparative Study

Abstract

BACKGROUND: Self-stigma remains one of the most vexing issues in psychiatry. It complicates the treatment and social functioning of patients with endogenous psychiatric disorders. Identifying the specific features of self-stigma depending on the type and duration of the endogenous mental illness can help solve this problem.

AIM: The aim of this study was to establish the level and specific features of self-stigma in patients with various types of chronic endogenous psychiatric disorders at different disease stages and to establish the correlation between the level of self-stigma and the attitude of the patient to his/her disease and treatment.

METHODS: Clinical psychopathology assessment, psychometric scales and questionnaires: “Positive and Negative Syndrome Scale” (PANSS), “Questionnaire for Self-Stigma Assessment in Mentally Ill Patients”, and Russian versions of the “Insight Scale for Psychosis” (ISP), and “Drug Attitude Inventory” (DAI-10). The cross-sectional study included 86 patients with endogenous mental illnesses (bipolar affective disorder and schizophrenia spectrum disorders.

RESULTS: The analysis of the results of the “Questionnaire for Self-Stigma Assessment in Mentally Ill Patients” showed that at the initial disease stages the highest level of self-stigma is observed in patients with bipolar affective disorder (M±σ=1.22±0.73; Me [Q1; Q3]=1.10 [0.83; 1.60]), while the lowest level was observed in patients with schizophrenia spectrum disorders (M±σ=0.86±0.53; Me [Q1; Q3]=0.77 [0.31; 1.25]). Patients with schizophrenia and schizoaffective disorder and a disease duration more than five years participating in a long-term comprehensive psychosocial rehabilitation program also demonstrated high rates of self-stigma (M±σ=1.20±0.57, Me [Q1; Q3]=1.26 [0.89; 1.47]). The study groups showed differences in terms of the structure of components of self-stigma and their severity; significant correlations were uncovered between the self-stigma parameters and the attitude of patients to their disease and therapy.

CONCLUSION: The results of this study contribute to a better understanding of the specific features of self-stigma in patients with various endogenous disorders at different stages of the disease. These data can be used as part of a comprehensive psychosocial treatment program for this patient cohort, as well as for future research.

Keywords

self-stigma / schizophrenia / schizoaffective disorder / bipolar affective disorder / first episode psychosis

References

[1] Goffman E. Stigma: Notes on the management of spoiled identity. Englewood Cliffs, N. J.: Prentice-Hall; 1963. 147 p.

[2] Yastrebov VS, Solokhina TA. [Stigmatization in psychiatry]. Mental health: social, clinical, organizational and scientific aspects. Proceedings of scientific and practical conference; October 31, 2016, Moscow. G.P. Kostyuk, editor. Moscow: KDU publisher; 2017. 524–531 p. Russian.

[3] Yu B, Chio F, Mak W, et al. Internalization process of stigma of people with mental illness across cultures: a meta-analytic structural equation modeling approach. Clinical Psychology Review. 2021;87:102029. doi: 10.1016/j.cpr.2021.102029

[4] Thornicroft G, Sunkel C, Aliev AA, et al. The Lancet Commission on ending stigma and discrimination in mental health. Lancet. 2022;400(10361):1438–1480. doi: 10.1016/S0140-6736(22)01470-2

[5] Latalova K, Kamaradova D, Prasko J. Perspectives on perceived stigma and self-stigma in adult male patients with depression. Neuropsychiatric Disease and Treatment. 2014;10:1399–1405. doi: 10.2147/NDT.S54081

[6] Rayan A, Aldaieflih M. Public stigma toward mental illness and its correlates among patients diagnosed with schizophrenia. Contemp Nurse. 2019;55(6):522–532. doi: 10.1080/10376178.2019.1670706

[7] Solokhina TA, Oshevsky DS, Barkhatova AN, et al. Self-stigmatization and targets of psychosocial intervention in patients with bipolar affective disorder. Mental Health. 2023;18(8):86–90.

[8] Neznanov NG, Shmukler AB, Kostyuk GP, Sofronov AG, et al. The first psychotic episode: Epidemiological aspects of care provision. Social and Clinical Psychiatry. 2019;28(3):5–11.

[9] Murru A, Carpiniello B. Duration of untreated illness as a key to early intervention in schizophrenia: A review. Neuroscience Letters. 2018;669:59–67. doi: 10.1016/j.neulet.2016.10.003

[10] Schizophrenia: Current science and clinical. 1st ed. Gaebel W, editor. Publishing house: John Wiley & Sons, Ltd; 2011. 272 p. doi: 10.1002/9780470978672

[11] Ratheesh A, Cotton SM, Davey CG, et al. Ethical considerations in preventive interventions for bipolar disorder. Early Intervention Psychiatry. 2017;11(2):104–112. doi: 10.1111/eip.12340

[12] Corrigan PW, Rao D. On the self-stigma of mental illness: Stages, disclosure, and strategies for change. Canadian Journal of Psychiatry. 2012;57(8):464–469. doi: 10.1177/070674371205700804

[13] Sorokin MY, Lutova NB, Bocharova MO, et al. Computational psychiatry approach to stigma subtyping in patients with mental disorders: Explicit and implicit internalized stigma. Consortium Psychiatricum. 2023;4(3):13–21. doi: 10.17816/CP6556

[14] Babin SM, Shlafer AM, Sergeeva NA. Compliance therapy for patients with schizophrenia. Medicinskaâ psihologiâ v Rossii. 2011;2. Available from: http://mprj.ru/archiv_global/2011_2_7/nomer/nomer11.php. Russian.

[15] Yastrebov VS, Trushchelev SA. Social images of psychiatry. S.S. Korsakov Journal of Neurology and Psychiatry. 2009;6(109):65–68.

[16] Yanos PT, Lysaker PH, Silverstein SM, et al. A randomized controlled-trial of treatment for self-stigma among persons diagnosed with schizophrenia-spectrum disorders. Social Psychiatry and Psychiatric Epidemiology. 2019;54(11):1363–1378. doi: 10.1007/s00127-019-01702-0

[17] Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261

[18] Mikhailova II. Self-stigmatization of mentally ill patients: description and typology. Psychiatry. 2004;2(8):23–30. Russian.

[19] Yastrebov VS, Enikolopov SN, Mikhailova II. Self-stigmatization of patients with major mental illnesses. S.S. Korsakov Journal of Neurology and Psychiatry. 2005;105(11):50–54.

[20] Birchwood M, Smith J, Drury V, et al. A self report Insight Scale for psychosis: Reliability, validity and sensitivity to change. Acta Psychiatrica Scandinavica. 1994;89(1):62–67. doi: 10.1111/j.1600-0447.1994.tb01487.x

[21] Hogan TP, Awad AG, Eastwood RA. Self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine. 1983;13(1):177–183. doi: 10.1017/s0033291700050182

[22] Otdel’nova KA. Determination of the required number of observations in social and hygienic studies. Sb. trudov 2-go MMI. 1980;150(6):18–22. Russian.

[23] Favre S, Richard-Lepouriel H. Self-stigma and bipolar disorder: A systematic review and best-evidence synthesis. Journal of Affective Disorders. 2023;335(15):273–288. doi: 10.1016/j.jad.2023.05.041

[24] Perich T, Mitchell PB, Vilus B. Stigma in bipolar disorder: a current review of the literature. Australian and New Zealand Journal of Psychiatry. 2022;56(9):1060–1064. doi: 10.1177/00048674221080708

[25] Gerlinger G, Hauser M, De Hert M, et al. Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions. World Psychiatry. 2013;12(2):155–164. doi: 10.1002/wps.20040

[26] Karidi MV, Vassilopoulou D, Savvidou E, et al. Bipolar disorder and self-stigma: a comparison with schizophrenia. Journal of Affective Disorders. 2015;184:209–215. doi: 10.1016/j.jad.2015.05.038

[27] Vasilchenko KF, Drozdovskii YuV. Internalized stigma and social adaptation levels among patients with first episode schizophrenia. Siberian Herald of Psychiatry and Addiction Psychiatry. 2018;1(98):30–35. doi: 10.26617/1810-3111-2018-1(98)-30-35

[28] Feldhaus T, Falke S, von Gruchalla L, et al. The impact of self-stigmatization on medication attitude in schizophrenia patients. Psychiatry Research. 2018;261(3):391–399. doi: 10.1016/j.psychres.2018.01.012

[29] Novick D, Montgomery W, Treuer T, et al. PMH10 — Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study. BMC Psychiatry. 2015;15:189. doi: 10.1186/s12888-015-0560-4

RIGHTS & PERMISSIONS

Solokhina T.A., Oshevsky D.S., Barkhatova A.N., Kuzminova M.V., Tyumenkova G.V., Alieva L.M., Shteinberg A.S., Churkina A.M.